Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.33K Hold
44
﹤0.01% 452
2025
Q4
$3.28K Hold
44
﹤0.01% 460
2025
Q3
$2.97K Hold
44
﹤0.01% 475
2025
Q2
$2.87K Buy
44
+7
+19% +$420 ﹤0.01% 463
2025
Q1
$2.29K Sell
37
-2
-5% -$133 ﹤0.01% 479
2024
Q4
$2.81K Buy
39
+2
+5% +$156 ﹤0.01% 463
2024
Q3
$3.01K Hold
37
﹤0.01% 447
2024
Q2
$2.75K Hold
37
﹤0.01% 452
2024
Q1
$2.88K Hold
37
﹤0.01% 445
2023
Q4
$2.64K Hold
37
﹤0.01% 413
2023
Q3
$2.57K Hold
37
﹤0.01% 391
2023
Q2
$3K Hold
37
﹤0.01% 376
2023
Q1
$2.99K Hold
37
﹤0.01% 356
2022
Q4
$2.77K Buy
+37
New +$2.63K ﹤0.01% 413
2021
Q4
Sell
-37
Closed -$2K 263
2021
Q3
$2K Buy
+37
New +$2.77K ﹤0.01% 429

Other funds holding HOLX

Red Tortoise LLC's HOLX Position: Q1 2026 in Review

Red Tortoise LLC held its Hologic (HOLX) position steady in Q1 2026 at 44 shares worth $3.33K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Red Tortoise LLC first reported a position in HOLX in Q3 2021 and has held it in 15 quarters since. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Red Tortoise LLC held 44 shares of Hologic worth $3.33K as of Q1 2026.
  • Red Tortoise LLC left its Hologic share count unchanged in Q1 2026.
  • Hologic made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #452 holding.
  • Red Tortoise LLC first reported a position in Hologic in Q3 2021 and has held it in 15 quarters since.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.